| cisplatin / Generic mfg. |
NCT00909402: A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas |
|
|
| Completed | 1b | 39 | US, Canada, Europe | BMS-833923, Cisplatin, Platinol-AQ, Capecitabine, Xeloda | Bristol-Myers Squibb, Exelixis | Stomach Neoplasms, Esophageal Neoplasms | 11/12 | 11/12 | | |
NCT00002711: Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus |
|
|
| Completed | 1 | 24 | US | chemotherapy, cisplatin, paclitaxel, low-LET electron therapy, low-LET photon therapy | Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI) | Esophageal Cancer | 10/00 | 10/00 | | |
NCT00215514: Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma |
|
|
| Completed | 1 | 25 | US | Epirubicin, Cisplatin, 5-Fluorouracil (5-FU), Radiation | Dana-Farber Cancer Institute, Brigham and Women's Hospital, Massachusetts General Hospital | Stomach Cancer, Gastric Cancer, Gastro-esophageal Junction Cancer | 11/03 | 07/14 | | |
NCT00005638: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer |
|
|
| Completed | 1 | | US | cisplatin, irinotecan hydrochloride, radiation therapy | Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI) | Esophageal Cancer, Gastric Cancer | 04/04 | 04/04 | | |
NCT00072332: Edotecarin and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors |
|
|
| Completed | 1 | | US | cisplatin, edotecarin | Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI) | Esophageal Cancer, Gastric Cancer, Unspecified Adult Solid Tumor, Protocol Specific | 12/05 | 12/09 | | |
EMD 72000-024, NCT00113581: Safety Study of EMD 72000 in Combination With ECX (Epirubicin, Cisplatin and Capecitabine) in Oesophagogastric Cancer |
|
|
| Completed | 1 | 26 | Europe | EMD 72000 (matuzumab) + ECX | Merck KGaA, Darmstadt, Germany | Esophageal Cancer, Gastric Cancer | 05/06 | 01/07 | | |
NCT00101907: Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Patients With Advanced Cancer |
|
|
| Terminated | 1 | 41 | US | AMG 706, Panitumumab, Vectibix, Gemcitabine, Gemzar, Cisplatin, cisplatinum, cis-diamminedichloridoplatinum(II) (CDDP) | Amgen | Lung Cancer, Pancreatic Cancer, Esophageal Cancer | 06/07 | 04/08 | | |
NCT01225523: Perioperative Vs. Preoperative Chemotherapy With Surgery in the Squamous Carcinoma of Esophagus |
|
|
| Completed | 1 | 350 | RoW | Paclitaxel; Cisplatin; 5-Fluorouracil, Paclitaxel; Cisplatin; 5-Fluorouracil; Capecitabine | Health Science Center of Xi'an Jiaotong University | Squamous Carcinoma of Esophagus, Esophagus Disorders | 12/08 | 01/10 | | |
NCT00601692: Irinotecan, Radiation Therapy, and Docetaxel With or Without Cisplatin in Treating Patients With Locally Advanced Esophageal Cancer |
|
|
| Completed | 1 | 27 | US | cisplatin, docetaxel, irinotecan hydrochloride, radiation therapy | Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI) | Esophageal Cancer | 12/09 | 12/09 | | |
NCT00701857: Pemetrexed, Cisplatin, and Radiation Therapy in Treating Patients With Esophageal or Gastroesophageal Junction Cancer |
|
|
| Completed | 1 | 10 | US | cisplatin, CDDP, Pemetrexed, Pemetrexed disodium, radiation therapy, RT | University of Arizona, National Cancer Institute (NCI) | Esophageal Cancer | 04/14 | 09/15 | | |
| Completed | 1 | 13 | Europe | Indomethacin | UMC Utrecht | Colorectal Neoplasms, Esophageal Neoplasms, Ovarian Neoplasms | 08/17 | 08/17 | | |
